WORLD-BRANDING-AWARDS
7.11.2022 14:26:37 CET | Business Wire | Press release
The fifteenth edition of the World Branding Awards saw over 3,500 brands from more than 45 countries nominated as “Brand of the Year”. Of these, less than 250 were declared Winners. The Awards Ceremony welcomed over 100 guests from around the world to celebrate the success and achievements of some of the World’s Best Brands, at the home of the awards, Kensington Palace.
Lurpak, Club Med, Yakult, Spotify, CoCo, Ikea, Amazon, Netflix, Neutrogena, Lego, Cadbury, Johnnie Walker, Ferrari, and Hennessy were announced as Global Winners at the prestigious awards ceremony.
Winners from Denmark include Bedre Naetter, Lagkagehuset, Bang & Olufsen, Tivoli Gardens. Other National Tier winners include Sokos Hotels (Finland), Carrefour (France), Haribo (Germany), Pertamina (Indonesia), Tuskys (Kenya), Amarula (South Africa). Silent Night (UK), and Toast Box (Singapore) to name a few.
Just 17 brands were selected to receive the Regional Tier award this year; Bosch, Media Markt, Sennheiser, SoundCloud, Al Abraaj Restaurants, Huawei, Carrefour, Optical 88, MR. D.I.Y., Elkjøp, Aramax, BreadTalk, Naturgy, H&M, Walrus Pump, Gems Pavilion, and CBRE. These brands were voted as the consumers favourite brand in 4 or more countries across 3 or more areas in a specific geographic region.
“The ceremony is a celebration of some of the best brands from across the globe. The Awards acknowledge the tireless effort put in by the brand's teams that build and maintain presence in an ever-evolving market” said Mr Danny Pek, Executive Director, World Branding Forum.
“This year over 150,000 consumers participated in the nomination process globally. On average there are only 5 winning brands in each country, further proving that winning a World Branding Award is indeed, a remarkable achievement” said Mr Richard Rowles, Chairman of the World Branding Forum.
The event was hosted by renowned television presenter, Jemma Forte and featured an exclusive insight into the future consumer provided by Chris Sanderson, Co-Founder of 'The Future Laboratory' the renowned consumer insights and trend forecasting consultancy.
For more information and the full list of winners, visit awards.brandingforum.org.
About the World Branding Awards
The World Branding Awards is the premier awards of the World Branding Forum, a registered non-profit organisation. The Awards recognises the achievements of some of the world’s best brands. For more information, visit https://awards.brandingforum.org
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221107005342/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Carnegie Mellon University and Cleveland Clinic Develop AI System to Interpret Cardiac MRI Scans with Enhanced Accuracy21.5.2026 14:05:00 CEST | Press release
Trained on more than 13,000 patient studies, novel system significantly outperforms existing models by up to 35% A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521762286/en/ A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. The novel system, called CMR-CLIP, is d
Otovo Hits 30,000 Customers in Under a Year, Tackling the Growing ‘Solar Service Crisis’21.5.2026 14:00:00 CEST | Press release
A growing wave of unsupported solar systems and rising electricity prices are creating strong demand for Otovo’s energy service platform Otovo ASA (“Otovo”), a leading global energy service provider for residential and commercial customers, today announced it has reached 30,000 customers across the U.S. and Europe. A total of 20,000 customers have enrolled in Otovo Care, the Company’s membership-based home and commercial energy service, which is powered by Otovo’s industry-leading AI platform, Endurance™. “Reaching 30,000 customers in less than year is proof positive that home and business owners value their power systems,” said William J. (John) Berger, CEO of Otovo. “The ‘solar service crisis’ that is leaving millions of orphaned energy systems without support is driving strong interest in our Otovo Care membership program. Every day your home or commercial power system is not working, you are throwing money away. Otovo’s rapid response service platform keeps you up and running, ensu
The Live Moment Effect: Genius Sports and MediaScience Study Finds Specific Moments in Live Sports Can Double Unaided Brand Recall21.5.2026 14:00:00 CEST | Press release
New research shows that brands aligned with emotionally heightened moments in live sports can improve ad effectiveness Genius Sports Limited (NYSE: GENI), a global leader in real-time sports data, today released new biometric research conducted with MediaScience showing that ads delivered immediately after emotionally heightened moments in live sports can double unaided brand recall. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521475265/en/ The Live Moment Effect report from Genius Sports and MediaScience. The study, The Live Moment Effect, finds that advertising effectiveness is significantly influenced by a viewer’s emotional state immediately before an ad is shown. In controlled biometric testing, ads shown after high-intensity sporting moments, such as near-scoring plays or crucial momentum shifts, delivered approximately double the unaided brand recall of baseline conditions. The Moment Before the Ad Matters The r
Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer21.5.2026 14:00:00 CEST | Press release
Precemtabart tocentecan (Precem-TcT) is investigated as a potential first-in-class anti-CEACAM5 ADC, for the treatment of metastatic CRC (mCRC) CEACAM5 is overexpressed in the majority of colorectal tumors (~90%), and requires no patient selection Significant unmet need remains for clinically meaningful innovation in colorectal cancer (CRC), the second leading cause of cancer death worldwide Not intended for Canada-, UK- or US-based media Merck, a leading science and technology company, today announced that the first patient has been dosed in the Phase 3 PROCEADE®-CRC-03 trial (NCT07549412). The study is evaluating precemtabart tocentecan (Precem‑TcT), a potential first‑in‑class investigational anti‑CEACAM5 antibody‑drug conjugate (ADC), for the treatment of metastatic colorectal cancer (mCRC). “Leveraging our novel payload‑linker technology, Precem‑TcT is the first CEACAM5‑targeted ADC in clinical studies with an exatecan payload, rationally designed for stability and enhanced cancer
Baszucki Group Funds Oxford University Clinical Trial of Ketogenic Therapy for Early Psychosis21.5.2026 13:00:00 CEST | Press release
Randomized controlled trial will evaluate both symptom progression and underlying biology Baszucki Group today announced a £1.17 million grant to support a randomized controlled trial at the University of Oxford assessing the feasibility, safety, and efficacy of a ketogenic diet for patients at clinical high risk of psychosis (CHR-P). Researchers will test this nutritional therapy's ability to improve patients' mental and physical health. This project builds on a growing body of research suggesting the potential of metabolic therapies in treating serious mental illness. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521877110/en/ Baszucki Group Funds £1.17 Million for University of Oxford Trial of Ketogenic Therapy for Early Psychosis Psychotic disorders carry a massive personal burden and are associated with a lower life expectancy. Psychosis does not develop immediately, but typically emerges following a period of early
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom